These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31085376)

  • 1. Antipsychotic-induced weight gain and birth weight in psychosis: A fetal programming model.
    Garriga M; Fernandez-Egea E; Mallorqui A; Serrano L; Oliveira C; Parellada E; Kirkpatrick B; Vieta E; Bernardo M; Garcia-Rizo C
    J Psychiatr Res; 2019 Aug; 115():29-35. PubMed ID: 31085376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic-Associated Weight Gain and Clinical Improvement Under Clozapine Treatment.
    Garriga M; Mallorquí A; Bernad S; Ruiz-Cortes V; Oliveira C; Amoretti S; Mezquida G; Bioque M; Molina O; Gómez-Ramiro M; Vieta E; Bernardo M; Parellada E; García-Rizo C
    J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):75-80. PubMed ID: 34928563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
    Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
    J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial.
    Alvarez-Jiménez M; González-Blanch C; Vázquez-Barquero JL; Pérez-Iglesias R; Martínez-García O; Pérez-Pardal T; Ramírez-Bonilla ML; Crespo-Facorro B
    J Clin Psychiatry; 2006 Aug; 67(8):1253-60. PubMed ID: 16965204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
    Perez-Iglesias R; Crespo-Facorro B; Amado JA; Garcia-Unzueta MT; Ramirez-Bonilla ML; Gonzalez-Blanch C; Martinez-Garcia O; Vazquez-Barquero JL
    J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of antipsychotic-induced metabolic alterations in mice: An experimental approach precluding psychosis as a predisposing factor.
    Singh R; Bansal Y; Sodhi RK; Saroj P; Medhi B; Kuhad A
    Toxicol Appl Pharmacol; 2019 Sep; 378():114643. PubMed ID: 31254565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors.
    Pérez-Iglesias R; Martínez-García O; Pardo-Garcia G; Amado JA; Garcia-Unzueta MT; Tabares-Seisdedos R; Crespo-Facorro B
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):41-51. PubMed ID: 24103107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever.
    Kluge M; Schuld A; Schacht A; Himmerich H; Dalal MA; Wehmeier PM; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T
    Psychoneuroendocrinology; 2009 Jan; 34(1):118-28. PubMed ID: 18835660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Stabilization of Weight Changes Following Treatment With Olanzapine, Risperidone, and Aripiprazole: A 12-Month Naturalistic Study of First Episode Psychosis.
    Mustafa S; Joober R; Iyer S; Shah J; Lepage M; Malla A
    J Clin Psychiatry; 2019 Aug; 80(5):. PubMed ID: 31509359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort).
    Ter Hark SE; Jamain S; Schijven D; Lin BD; Bakker MK; Boland-Auge A; Deleuze JF; Troudet R; Malhotra AK; Gülöksüz S; Vinkers CH; Ebdrup BH; Kahn RS; Leboyer M; Luykx JJ
    J Psychopharmacol; 2020 May; 34(5):524-531. PubMed ID: 32126890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.
    Kelly AC; Sheitman BB; Hamer RM; Rhyne DC; Reed RM; Graham KA; Rau SW; Gilmore JH; Perkins DO; Peebles SS; VanderZwaag CJ; Jarskog LF
    J Clin Psychopharmacol; 2014 Aug; 34(4):441-5. PubMed ID: 24943389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course.
    Gebhardt S; Haberhausen M; Heinzel-Gutenbrunner M; Gebhardt N; Remschmidt H; Krieg JC; Hebebrand J; Theisen FM
    J Psychiatr Res; 2009 Mar; 43(6):620-6. PubMed ID: 19110264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of birth weight and the development of antipsychotic induced adiposity in individuals with treatment resistant schizophrenia.
    Ziauddeen H; Garcia-Rizo C; Bernardo M; Kirkpatrick B; Ozanne SE; Jones PB; Fernandez-Egea E
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):972-8. PubMed ID: 27107738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications.
    Tek C; Kucukgoncu S; Guloksuz S; Woods SW; Srihari VH; Annamalai A
    Early Interv Psychiatry; 2016 Jun; 10(3):193-202. PubMed ID: 25962699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of novel antipsychotics on glucose and lipid levels.
    Wirshing DA; Boyd JA; Meng LR; Ballon JS; Marder SR; Wirshing WC
    J Clin Psychiatry; 2002 Oct; 63(10):856-65. PubMed ID: 12416594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.
    Cooper GD; Harrold JA; Halford JC; Goudie AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):428-36. PubMed ID: 17933447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin and leptin levels in patients with schizophrenia or related psychoses--a comparison between different antipsychotic agents.
    Melkersson KI; Hulting AL
    Psychopharmacology (Berl); 2001 Mar; 154(2):205-12. PubMed ID: 11314683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.